BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12875884)

  • 21. Synthesis and antimicrobial evaluation of naphtho[2,1-b]pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives.
    Eid FA; Abd El-Wahab AH; Ali GA; Khafagy MM
    Acta Pharm; 2004 Mar; 54(1):13-26. PubMed ID: 15050041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of 4,6-disubstituted- and 4,5,6-trisubstituted-2-phenyl-pyrimidines and their affinity towards A1 adenosine receptors.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A
    Farmaco; 1997 Jan; 52(1):61-5. PubMed ID: 9181684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations.
    Pastorin G; Da Ros T; Bolcato C; Montopoli C; Moro S; Cacciari B; Baraldi PG; Varani K; Borea PA; Spalluto G
    J Med Chem; 2006 Mar; 49(5):1720-9. PubMed ID: 16509587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
    Bioorg Med Chem; 2010 Jul; 18(14):5282-90. PubMed ID: 20541425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines.
    Neustadt BR; Liu H; Hao J; Greenlee WJ; Stamford AW; Foster C; Arik L; Lachowicz J; Zhang H; Bertorelli R; Fredduzzi S; Varty G; Cohen-Williams M; Ng K
    Bioorg Med Chem Lett; 2009 Feb; 19(3):967-71. PubMed ID: 19109019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and isomerization of some novel pyrazolopyrimidine and pyrazolotriazolopyrimidine derivatives.
    Rashad AE; Shamroukh AH; Abdel-Megeid RE; Ali HS
    Molecules; 2014 Apr; 19(5):5459-69. PubMed ID: 24776812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facile synthesis of fused 1,2,4-triazolo[1,5-c]pyrimidine derivatives as human adenosine A3 receptor ligands.
    Okamura T; Kurogi Y; Hashimoto K; Nishikawa H; Nagao Y
    Bioorg Med Chem Lett; 2004 May; 14(10):2443-6. PubMed ID: 15109629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist.
    Maconi A; Pastorin G; Da Ros T; Spalluto G; Gao ZG; Jacobson KA; Baraldi PG; Cacciari B; Varani K; Moro S; Borea PA
    J Med Chem; 2002 Aug; 45(17):3579-82. PubMed ID: 12166930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tricyclic heteroaromatic systems. 2-Phenyl-1,2,4-triazolo[1,5-c][1,3]benzoxazin-5-one: a novel benzodiazepine receptor ligand.
    Catarzi D; Cecchi L; Colotta V; Filacchioni ; Martini C; Giusti L; Lucacchini A; Valle G
    Farmaco; 1994 Feb; 49(2):89-92. PubMed ID: 8003185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. VII. Synthesis and inhibition of benzodiazepine receptor binding of some 4,5-dihydro-tetrazolo[5,1-d]-1,5-benzothiazepines and 5-phenyl-s-triazolo[3,4-d]-1,5-benzothiazepines.
    Ambrogi V; Grandolini G; Perioli L; Giusti L; Lucacchini A; Martini C
    Farmaco; 1993 May; 48(5):665-76. PubMed ID: 8393678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists.
    Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Simorini F; Salerno S; Sergianni V; Tuccinardi T; Martinelli A; Cosimelli B; Greco G; Novellino E; Ciampi O; Trincavelli ML; Martini C
    J Med Chem; 2007 Nov; 50(23):5676-84. PubMed ID: 17927167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of 2,7-diaminosubstituted-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonitriles by solid-phase synthesis.
    Cavallaro CL; Harikrishnan LS; Chi F; Dodd D; Purandare A
    J Comb Chem; 2008; 10(1):28-30. PubMed ID: 17994705
    [No Abstract]   [Full Text] [Related]  

  • 34. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
    Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
    J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II.
    Biagi G; Giorgi I; Livi O; Scartoni V; Betti L; Giannaccini G; Trincavelli ML
    Eur J Med Chem; 2002 Jul; 37(7):565-71. PubMed ID: 12126775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antimicrobial activity of certain new 1,2,4-triazolo[1,5-a]pyrimidine derivatives.
    Mostafa YA; Hussein MA; Radwan AA; Kfafy Ael-H
    Arch Pharm Res; 2008 Mar; 31(3):279-93. PubMed ID: 18409039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives.
    Massari S; Desantis J; Nannetti G; Sabatini S; Tortorella S; Goracci L; Cecchetti V; Loregian A; Tabarrini O
    Org Biomol Chem; 2017 Sep; 15(37):7944-7955. PubMed ID: 28902220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
    Varani K; Gessi S; Dalpiaz A; Ongini E; Borea PA
    Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.
    Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1209-14. PubMed ID: 8819504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of some new pyrimidine and fused pyrimidine derivatives (Part I).
    Ahmed GA; el-Bahai S; Nasser ; Abd el-Salam M
    Boll Chim Farm; 2003; 142(2):72-5. PubMed ID: 12705094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.